cas 1415226-40-2|| where to buy 5-(3-Chlorophenyl)-3-hydroxypicolinic acid

Название продукции:5-(3-Chlorophenyl)-3-hydroxypicolinic acid

IUPAC Name:5-(3-chlorophenyl)-3-hydroxypyridine-2-carboxylic acid

: CAS：1415226-40-2; Молекулярная формула：C12H8ClNO3; Чистота：97%

Упаковочная единица	Доступно для заказа	Цена ($)
CM249306-100mg	in stock	ƩƩ
CM249306-250mg	in stock	Ǖșň
CM249306-1g	in stock	șňǺ
CM249306-5g	1-2 Weeks	ǺƩƅ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1415226-40-2 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:1415226-40-2; Молекулярная формула:C12H8ClNO3; Точка плавления:-; Smiles-код:O=C(C1=NC=C(C2=CC=CC(Cl)=C2)C=C1O)O; Плотность:

: Номер в каталоге:CM249306; Молекулярная масса:249.65; Точка кипения:; Номер Mdl:MFCD30802547; Хранение:

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Vadadustat; March 27, 2024, Akebia received FDA approval of Vafseo(vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
Vafseo(vadadustat) tablets is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor that activates the physiologic response to hypoxia to stimulate endogenous production of erythropoietin, increasing hemoglobin and red blood cell production to manage anemia.